BMO Capital Markets Cuts Chemours (NYSE:CC) Price Target to $27.00
Chemours (NYSE:CC – Get Free Report) had its price objective cut by equities researchers at BMO Capital Markets from $34.00 to $27.00 in a report released on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the specialty chemicals company’s stock. BMO Capital Markets’ target price suggests a potential upside of 53.80% from the […]
Chemours (NYSE:CC – Get Free Report) had its price objective cut by equities researchers at BMO Capital Markets from $34.00 to $27.00 in a report released on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the specialty chemicals company’s stock. BMO Capital Markets’ target price suggests a potential upside of 53.80% from the […]
